| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,000 |
2,595 |
$160K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
167 |
95 |
$56K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
388 |
314 |
$30K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
354 |
337 |
$26K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
317 |
250 |
$22K |
| 96127 |
|
854 |
816 |
$20K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
439 |
421 |
$20K |
| 99384 |
|
178 |
175 |
$18K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
209 |
201 |
$17K |
| 99383 |
|
163 |
161 |
$15K |
| 90671 |
|
109 |
69 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
712 |
639 |
$11K |
| 87631 |
|
68 |
55 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
175 |
147 |
$6K |
| 90698 |
|
352 |
257 |
$6K |
| 90651 |
|
128 |
124 |
$5K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
137 |
94 |
$5K |
| 90686 |
|
258 |
212 |
$4K |
| 96160 |
|
159 |
149 |
$3K |
| 99000 |
|
118 |
104 |
$3K |
| 90680 |
|
136 |
85 |
$2K |
| 90677 |
|
89 |
78 |
$2K |
| 90744 |
|
130 |
112 |
$2K |
| 90633 |
|
128 |
105 |
$2K |
| 90656 |
|
120 |
117 |
$2K |
| 90619 |
|
122 |
111 |
$2K |
| 99382 |
|
20 |
16 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
53 |
47 |
$2K |
| 90716 |
|
110 |
106 |
$2K |
| 99381 |
|
19 |
13 |
$2K |
| 90707 |
|
106 |
101 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
100 |
90 |
$2K |
| 90670 |
|
71 |
65 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
30 |
29 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
55 |
53 |
$1K |
| 90621 |
|
56 |
52 |
$935.76 |
| 90715 |
|
51 |
50 |
$785.37 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
36 |
17 |
$672.95 |
| 90713 |
|
43 |
42 |
$651.69 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
46 |
40 |
$580.33 |
| D1206 |
Topical application of fluoride varnish |
15 |
15 |
$390.00 |
| 99173 |
|
53 |
53 |
$373.67 |
| 90700 |
|
16 |
15 |
$217.23 |